• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Public Health . SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation str

tetano

Editor, Senior Moderator
J Infect Public Health


. 2021 Apr 23;14(7):863-875.
doi: 10.1016/j.jiph.2021.04.005. Online ahead of print.
SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies-a narrative review


Rakesh Kumar[SUP] 1 [/SUP], Cut Meurah Yeni[SUP] 2 [/SUP], Niken Asri Utami[SUP] 3 [/SUP], Rupali Masand[SUP] 4 [/SUP], Rajesh Kumar Asrani[SUP] 5 [/SUP], Shailesh Kumar Patel[SUP] 6 [/SUP], Akshay Kumar[SUP] 7 [/SUP], Mohd Iqbal Yatoo[SUP] 8 [/SUP], Ruchi Tiwari[SUP] 9 [/SUP], Senthilkumar Natesan[SUP] 10 [/SUP], Kranti Suresh Vora[SUP] 11 [/SUP], Firzan Nainu[SUP] 12 [/SUP], Muhammad Bilal[SUP] 13 [/SUP], Manish Dhawan[SUP] 14 [/SUP], Talha Bin Emran[SUP] 15 [/SUP], Tauseef Ahmad[SUP] 16 [/SUP], Harapan Harapan[SUP] 17 [/SUP], Kuldeep Dhama[SUP] 18 [/SUP]



Affiliations

Abstract

The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global public health problem. The SARS-CoV-2 triggers hyper-activation of inflammatory and immune responses resulting in cytokine storm and increased inflammatory responses on several organs like lungs, kidneys, intestine, and placenta. Although SARS-CoV-2 affects individuals of all age groups and physiological statuses, immune-compromised individuals such as pregnant women are considered as a highly vulnerable group. This review aims to raise the concerns of high risk of infection, morbidity and mortality of COVID-19 in pregnant women and provides critical reviews of pathophysiology and pathobiology of how SARS-CoV-2 infection potentially increases the severity and fatality during pregnancy. This article also provides a discussion of current evidence on vertical transmission of SARS-CoV-2 during pregnancy and breastfeeding. Lastly, guidelines on management, treatment, preventive, and mitigation strategies of SARS-CoV-2 infection during pregnancy and pregnancy-related conditions such as delivery and breastfeeding are discussed.

Keywords: COVID-19; Pregnant women; Prevention; SARS-CoV-2; Vertical transmission.
 
Back
Top Bottom